0001213900-26-036609
SEC filingFiscal 2025 delivered narrowed operating and net losses for Movano Inc. driven by targeted cost cuts, offsetting a steep year-over-year decline in legacy healthcare revenue.
The 57.3% year-over-year decline in FY2025 revenue to $433.0K stems directly from reduced marketing efforts for the company’s flagship Wellness Ring Elements product line, a shift initiated in the first quarter of 2024 that cut sales volume for the period. Revenue was recognized upon transfer of control of the physical wellness devices to customers, consistent with the company’s existing revenue recognition policy. Gross margin for the year came in at -424.9%, reflecting the high fixed cost base of the legacy healthcare segment relative to the current low revenue scale.
Company-wide cost reduction efforts delivered meaningful improvements to operating and loss metrics in FY2025. Operating loss narrowed 36.0% year-over-year to $15.5M, driven primarily by reduced SG&A headcount and lower overall marketing spend during the period. Net loss improved 22.9% year-over-year to $18.3M, as these expense cuts partially offset the impact of lower top-line revenue. Operating cash burn halved year-over-year to $11.3M, with free cash flow totaling -$11.3M for the year, as capital expenditures remained flat at $8.0K with no material fixed asset investments made for the legacy business. The fair value of all stock option grants issued during the period was estimated on the grant date using the Black-Scholes option pricing model, consistent with prior period accounting practices.
Management anticipates the company will continue to generate annual losses for the foreseeable future as it executes its current business plan, excluding any non-recurring items. The company has not paid dividends on its common stock to date and has no current plans to initiate dividend payments. The liquidity and financial performance discussion in this filing reflects only the historical operations of the legacy healthcare business, and management notes there is risk the company could deplete its capital resources sooner than currently expected if operating results do not meet internal projections.